✦ LIBER ✦

Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor

✍ Scribed by Elizabeth Iorns, Toby M. Ward, Sonja Dean, Anna Jegg, Dafydd Thomas, Nirupa Murugaesu, David Sims, Costas Mitsopoulos, Kerry Fenwick, Iwanka Kozarewa, Cristina Naceur-Lombarelli, Marketa Zvelebil, Clare M. Isacke, Christopher J. Lord, Alan Ashworth, et al

Book ID: 118796638
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 703 KB
Volume: 135
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-012-2068-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The in vitro and in vivo anti-tumor effe

The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer

✍ Miyun Oh; Jeong-Yeon Lee; Dong-Hui Shin; Ji-Hye Park; Tingting Oian; Hyun-Jun Ki 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 637 KB

The in vitro and in vivo anti-tumor effe

The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer

✍ Miyun Oh; Jeong-Yeon Lee; Dong-Hui Shin; Ji-Hye Park; Tingting Oian; Hyun-Jun Ki 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 796 KB